Head of Investor Relations Welcome to the Q4 and full year 2024 conference call for investors and analysts. As usual, you can find the slides on sanofi.com. Please turn to Slide 3. Here we have the ...

Roche Holding AG delivered a strong set of 2024 earnings. Guidance for 2025 suggests this will be a transitional year ahead, ...

Welcome to the Q2 fiscal-year 2025 ResMed earnings conference call. My name is Matt and I'll be your operator for today's call. (Operator Instructions) Please note that this conference call is being ...

Q2 2025 Earnings Call Transcript January 30, 2025 ResMed Inc. beats earnings expectations. Reported EPS is $2.43, expectations were $2.32. Operator: Welcome to the Q2 Fiscal Year 2025 ResMed Earnings ...

Synairgen PLC is a respiratory drug discovery and development company. It is engaged in the drug discovery and development of therapies for respiratory diseases, particularly in the areas, including ...

During and after an exacerbation, mental recovery involves taking care of both your physical and mental health. Resting, ...

You must go to a doctor to know for sure whether you have COPD. That’s because there are things to consider for a diagnosis. Some people have asthma and COPD at the same time. If you have ...

Although RMD has re-rated from its share price low of around $21.50 in October 2023, it has only just surpassed its all-time ...

Nov. 27, 2024 — A recent trial finds an injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets, reducing the need for further ...

Chronic obstructive pulmonary disease (COPD) is an irreversible inflammatory disease of the lungs that makes it more difficult to breathe over time. The disease causes changes to the tissues inside ...

The root of the U.S.’s high prescription drug prices lies in its unique system, which allows pharmaceutical manufacturers to ...